Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 7/20 | 0.42 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | TNKS | O95271 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 2/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30233361 | 0.99 | LPL (0.40) | LPLLIPGPDK2TNKSKIF11 | |
| SCHEMBL21878519 | 0.99 | LPL (0.40) | LPLLIPGPDK2TNKSKIF11 | |
| SCHEMBL20699261 | 0.88 | LIPG (0.58) | LPLLIPGPDK2TNKSKIF11 | |
| SCHEMBL23624415 | 0.86 | LIPG (0.55) | LPLLIPGTNKS | |
| SCHEMBL20944840 | 0.86 | LIPG (0.57) | LPLLIPG | |
| SCHEMBL24130907 | 0.84 | LPL (0.37) | LPLLIPGPDK2TNKSSLC22A12 | |
| SCHEMBL16557794 | 0.83 | TNKS (0.37) | LPLLIPGTNKSPGRALDH1A1 | |
| SCHEMBL15411720 | 0.83 | LPL (0.42) | LPLLIPGPDK2KIF11MMP3 | |
| SCHEMBL17035144 | 0.82 | LIPG (0.51) | LPLLIPG | |
| SCHEMBL29587879 | 0.82 | LIPG (0.51) | LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220220083-A1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE ELEMENT | HODOGAYA CHEMICAL CO., LTD. (JP) | 2022-07-14 | — | — | US | disclosed |
| WO-2020166630-A1 | COMPOUND HAVING BENZAZOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | 保土谷化学工業株式会社 | 2020-08-20 | — | — | WO | disclosed |
| US-20200181096-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200181096-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CYP1A1, AHR | LPL 3204/4885LIPG 4601/4885PDK2 2192/4885 |
| US-20220220083-A1 | COMPOUND HAVING BENZOTRIAZOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE ELEMENT | POU2F2, EBPL, POU2F1 | LPL 2171/4885LIPG 1510/4885PDK2 3114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.